All In Biotech

Drug Trial Radar · NCT06559150

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

A Phase II, Randomized, Double-Blind, Placebo- Controlled Study of Ensifentrine in Subjects With Non-Cystic Fibrosis Bronchiectasis

Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 284 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

284

Planned (sponsor's estimate)

Start

Sep 11, 2024

Primary completion

Sep 24, 2027

Study completion Sep 24, 2027

Sponsor

Sponsor type
Industry
First posted
Aug 19, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of ensifentrine inhalation suspension (3 mg) delivered twice daily via standard jet nebulizer up to 52 weeks, compared to placebo, in participants with non-cystic fibrosis bronchiectasis (NCFBE).

Conditions

  • Non-cystic Fibrosis Bronchiectasis

Interventions

  • Nebulized Ensifentrine Suspension; 3 mgDrug

    Administered by a standard jet nebulizer, twice daily up to a maximum of 52 weeks

  • Nebulized Placebo SolutionDrug

    Administered by a standard jet nebulizer, twice daily up to a maximum of 52 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of protocol-defined pulmonary exacerbations (number of events per subject-year)Time frame: Through study completion (up to 52 weeks)

Locations

51 sites in 4 countries. Site status is shown where the registry gives one.

  • Kirklin Clinic of UAB Hospital

    Birmingham, Alabama · Recruiting

  • So Cal Institute for Respiratory Diseases, Inc.

    Los Angeles, California · Recruiting

  • University of California Davis Medical Center

    Sacramento, California · Recruiting

  • National Jewish Health Main Campus

    Denver, Colorado · Recruiting

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia · Recruiting

  • University of Miami

    Miami, Florida · Recruiting

  • Emory University at Saint Joseph Pulmonary Clinic

    Atlanta, Georgia · Recruiting

  • Augusta University

    Augusta, Georgia · Recruiting

  • ASHA Clinical Research

    Hammond, Indiana · Recruiting

  • University of Iowa

    Iowa City, Iowa · Recruiting

  • University of Kansas Medical Center-Kansas City

    Kansas City, Kansas · Recruiting

  • Massachusetts General Hospital- 55 Fruit St

    Boston, Massachusetts · Recruiting

  • University of Michigan Hospital

    Ann Arbor, Michigan · Recruiting

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Recruiting

  • NYU Langone Health Pulmonary and Critical Care Associates, P.C. - BRANY - PPDS

    New York, New York · Recruiting

  • University of North Carolina

    Chapel Hill, North Carolina · Recruiting

  • Accellacare of Wilmington

    Wilmington, North Carolina · Terminated

  • Southeastern Research Center

    Winston-Salem, North Carolina · Recruiting

  • Ohio State University

    Columbus, Ohio · Recruiting

  • Oregon Health and Science University

    Portland, Oregon · Recruiting

  • Temple University Hospital

    Philadelphia, Pennsylvania · Recruiting

  • Medical University of South Carolina (MUSC) - PPDS

    Charleston, South Carolina · Recruiting

  • Velocity Clinical Research - Spartanburg - PPDS

    Spartanburg, South Carolina · Recruiting

  • Velocity Clinical Research - Union - PPDS

    Union, South Carolina · Recruiting

  • Clinical Trials Center of Middle Tennessee

    Franklin, Tennessee · Recruiting

  • The Respire Institute

    Houston, Texas · Recruiting

  • UT Texas Health Science at Tyler

    Tyler, Texas · Recruiting

  • TPMG Clinical Research

    Williamsburg, Virginia · Recruiting

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    Bologna, Italy · Recruiting

  • Fondazione IRCCS Policlinico San Matteo

    Pavia, Italy · Recruiting

  • Fondazione IRCCS San Gerardo dei Tintori

    Monza, Lombardi, Italy · Recruiting

  • Istituto Clinico Humanitas

    Rozzano, Lombardy, Italy · Recruiting

  • AOU Policlinico Gaspare Rodolico-San Marco Presidio Ospedaliero Gaspare Rodolico

    Catania, Sicily, Italy · Recruiting

  • Hospital Universitario A Coruña

    A Coruña, Spain · Recruiting

  • Hospital del Mar

    Barcelona, Spain · Recruiting

  • Hospital Clinic de Barcelona

    Barcelona, Spain · Recruiting

  • Hospital Universitario Vall d'Hebron - PPDS

    Barcelona, Spain · Recruiting

  • Hospital Universitario de Bellvitge

    Barcelona, Spain · Recruiting

  • Hospital General Universitario Gregorio Marañon

    Madrid, Spain · Recruiting

Showing 40 of 51 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.